Showing results (311-320 of 346) with videos related to

Sort By:
Pageof 35
Scientific Data|March 28, 2023
SARS-CoV2 billion-compound dockingDavid M Rogers, Rupesh Agarwal, Josh V Vermaas, et al.
Journal of Medicinal Chemistry|June 27, 2017
Identification and Structure-Activity Relationships of Novel Compounds that Potentiate the Activities of Antibiotics in Escherichia coliKeith M Haynes, Narges Abdali, Varsha Jhawar, et al.
Biophysical Journal|January 30, 2019
Identification of Binding Sites for Efflux Pump Inhibitors of the AcrAB-TolC Component AcrAZbigniew M Darzynkiewicz, Adam T Green, Narges Abdali, et al.
Antimicrobial Agents and Chemotherapy|July 8, 2025
Mutations in the proximal binding site and F-loop of AdeJ confer resistance to efflux pump inhibitorsAysegul Saral Sariyer, Inga V Leus, Rushikesh Tambat, et al.
Bioinformatics (Oxford, England)|February 15, 2013
GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkitSander Pronk, Szilárd Páll, Roland Schulz, et al.
Molecular Endocrinology (Baltimore, Md.)|October 7, 2015
Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral TissuesMin Pi, Karan Kapoor, Yunpeng Wu, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|January 8, 2025
Toxic Effects of Butanol in the Plane of the Cell MembraneLuoxi Tan, Haden L Scott, Micholas Dean Smith, et al.
ACS Infectious Diseases|November 3, 2016
Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux PumpNarges Abdali, Jerry M Parks, Keith M Haynes, et al.
Journal of Integrative Medicine|July 16, 2024
Scientific guidelines for preclinical research on potentised preparations manufactured according to current pharmacopoeias-the PrePoP guidelinesAlexander L Tournier, Leoni V Bonamin, Susann Buchheim-Schmidt, et al.
Pageof 35